Head-to-head · Cost-Efficiency Index
Ivologist vs Novi
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Ivologist
Shoppers who want a named, LegitScript-certified multi-prescriber telehealth practice with all-50-state coverage.
Visit IvologistNovi
Shoppers drawn to the lowest flat headline price in this batch, if they're comfortable that dosing, coverage states, and pharmacy details aren't published anywhere on the site.
Visit NoviThe verdict
Ivologist and Novi tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with Ivologist (ranked #101, a hair above #105) — Shoppers who want a named, LegitScript-certified multi-prescriber telehealth practice with all-50-state coverage. But Novi is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Ivologist.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Ivologist | Novi |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $149/mo (starting dose, compounded) | $99/mo (all doses, promotional rate, compounded) |
| Tirzepatide / mo | $249/mo (starting dose, compounded) | $133/mo (all doses, promotional rate, compounded) |
| Semaglutide / yr (modeled) | $1,788 | $1,188 |
| Tirzepatide / yr (modeled) | $2,988 | $1,596 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #101 | #105 |
Ivologist
69/100Where the value is
- LegitScript certified with licensed 503A & 503B US pharmacies
- Over a dozen named prescribers publicly listed rather than an anonymous provider pool
- All 50 states served per the site's own banner copy
The tradeoffs
- The discounted 'what you pay today' monthly price and the program total shown directly beneath it don't reconcile — the total appears calculated at the pre-discount rate, not the discounted one
- 'Starter Program' pricing covers only the first 11-12 weeks; ongoing maintenance pricing is on a separate, unexplored 'Maintenance Programs' page
Novi
69/100Where the value is
- Lowest advertised entry price in this entire batch for both drugs ($99 semaglutide / $133 tirzepatide)
- LegitScript certified, independently verifiable via the linked legitscript.com record
- States one flat price per dose with no separate visit fee and free shipping
The tradeoffs
- No published mg dose, supply duration, state-coverage list, named medical director, or named compounding pharmacy anywhere on the site or its help center — the least transparent operational disclosure of any company researched in this batch
- The advertised $99/$133 rate is displayed against a live countdown timer ('price increases in...') next to a claimed $299 original price, a scarcity tactic that makes it unclear whether this is a genuine standing rate or a recurring promotional one
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.